Search

Author/Creator Pietrantonio, F.

1. L07Baseline characteristics and survival outcomes of advanced gastric cancer patients treated with two or more lines of chemotherapy: results from a large Italian cohort. (26th September 2015)

Authors:
Ferrari, L.; Fontanella, C.; Uccello, M.; Pasquini, G.; Bozzarelli, S.; Filippi, R.; Imperatori, M.; Ferrara, D.; Tomasello, G.; Brunetti, O.; Pietrantonio, F.; Bellu, L.; Lutrino, E.S.; Melisi, D.; Antonuzzo, L.; Musettini, G.; Cordio, S.; Vivaldi, C.; Rimassa, L.; Aprile, G.
Journal:
Annals of oncology
Issue:
Volume 26(2015)Supplement 6
Page Start:
vi
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 2357 Prognostic factors in 709 advanced gastric cancer patients exposed to second-line therapy. (September 2015)

Authors:
Fontanella, C.; Fanotto, V.; Uccello, M.; Vasile, E.; Bozzarelli, S.; Filippi, R.; Santini, D.; Rosati, G.; Tomasello, G.; Silvestris, N.; Pietrantonio, F.; Bergamo, F.; Cinieri, S.; Melisi, D.; Antonuzzo, L.; Fornaro, L.; Cordio, S.; Pasquini, G.; Rimassa, L.; Aprile, G.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S454
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 2265 Capecitabine, oxaliplatin and irinotecan (COI regimen) as perioperative treatment of resectable gastric or gastroesophafageal junction (GEJ) cancer. (September 2015)

Authors:
Berenato, R.; Pellegrinelli, A.; Pietrantonio, F.; Niger, M.; Caporale, M.; De Braud, F.; Ricchini, F.; Maggi, C.; Di Bartolomeo, M.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S421
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 2190 Discovery of new molecular subtypes of non-hypermutated metastatic colorectal cancer (mCRC) through a next-generation sequencing (NGS) approach. (September 2015)

Authors:
Pietrantonio, F.; Perrone, F.; Cremolini, C.; Orlandi, A.; Niger, M.; Caporale, M.; Berenato, R.; Antoniotti, C.; Loupakis, F.; Tamborini, E.; Milione, M.; Settanni, G.; Busico, A.; De Braud, F.; Di Bartolomeo, M.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S396
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 2203 Association with programmed death ligand-1 (PDL-1) expression and Helicobacter pylori infection in patients with "non diffusive type" gastric carcinoma radically resected. (September 2015)

Authors:
Di Bartolomeo, M.; Pellegrinelli, A.; Iacovelli, R.; Pietrantonio, F.; Berenato, R.; Caporale, M.; Niger, M.; Barbera, M.; Labianca, R.; Martoni, A.; Rosati, G.; Nitti, D.; Boni, C.; Bajetta, E.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S400
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 2366 Metronomic capecitabine and bevacizumab is an active combination in patients with relapsed peritoneal pseudomyxoma. (September 2015)

Authors:
Maggi, C.; De Braud, F.; Di Bartolomeo, M.; Perrone, F.; Tamborini, E.; Milione, M.; Deraco, M.; Kusamura, S.; Baratti, D.; Berenato, R.; Caporale, M.; Consonni, P.V.; Niger, M.; Bossi, I.; Leo, E.; Pelosi, G.; Pietrantonio, F.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S458
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 416 Variant Alleles in Factor V Leiden (FVL), Prothrombin, Plasminogen Activator Inhibitor-1 (PAI-1) or Methylenetetrahydrofolate Reductase (MTHFR) and risk of thromboembolic events (TEE) in metastatic colorectal cancer (mCRC) patients. (September 2015)

Authors:
Falvella, F.S.; Cremolini, C.; Miceli, R.; Nichetti, F.; Cheli, S.; Antoniotti, C.; Infante, G.; Martinetti, A.; Loupakis, F.; Bartolomeo, M. Di; Marmorino, F.; Sottotetti, E.; Bossi, I.; Berenato, R.; Caporale, M.; Niger, M.; Colombo, A.; Braud, F. De; Clementi, E.; Pietrantonio, F.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S83
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. SP-0453 Targeting DNA repair to improve immunesurveillance and restrict cancer growth. (April 2019)

Authors:
Germano, G.; Lamba, S.; Rospo, G.; Barault, L.; Magrì, A.; Maione, F.; Russo, M.; De Braud, F.; Marsoni, S.; D'incalci, M.; Sartore-Bianchi, A.; Siena, S.; Pietrantonio, F.; Di Nicolantonio, F.; Bardelli, A.
Journal:
Radiotherapy and oncology
Issue:
Volume 133(2019)Supplement 1
Page Start:
S235
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research. Issue 12 (16th September 2016)

Authors:
Pietrantonio, F.; Caporale, M.; Morano, F.; Scartozzi, M.; Gloghini, A.; De Vita, F.; Giommoni, E.; Fornaro, L.; Aprile, G.; Melisi, D.; Berenato, R.; Mennitto, A.; Volpi, C. C.; Laterza, M. M.; Pusceddu, V.; Antonuzzo, L.; Vasile, E.; Ongaro, E.; Simionato, F.; de Braud, F.
Journal:
International journal of cancer
Issue:
Volume 139:Issue 12(2016:Dec. 15)
Page Start:
2859
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗